Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Cardiovascular Medicine

Cardiac Vagal Neurostimulation for Ventricular Rate Control During Atrial Fibrillation

There are two broad strategic treatment options for AF treatment: rhythm control and rate control.
CME credit is no longer available for this conference.

Course Authors

Youhua Zhang, M.D., Ph.D., and Todor N. Mazgalev, Ph.D.

Release Date: 08/16/2010

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the current status of efforts to control the atrial fibrillation epidemic

  • Describe the rhythm versus rate control approaches

  • Discuss the intracardiac autonomic nervous system, and specifically the selective vagal control of atrioventricular nodal conduction.

  • Discuss state-of-the-art new technologies utilizing implantable neural electrostimulators to achieve selective modulation of the intracardiac autonomic nervous system in order to control AV conduction and ventricular rate during atrial fibrillation.

  • Assess critically different therapeutic options, including the latest application of implantable neural electrostimulators.

 

TERMS AND CONDITIONS

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Current Management of Hypertension

The link between elevated blood pressure and cardiovascular disease is firmly established. How to treat HBP is less certain.
Authors: Aditya Khetan, M.B.B.S., Richard A Josephson, M.S., M.D. and Sri Krishna Madan Mohan M.B.B.S.
View Course
More

Myocardial Infarction

Significant progress has been made in the primary and secondary prevention of myocardial infarction, but it remains a leading cause of death.
Authors: Richard Josephson, M.S., M.D., and Sri K. Madan Mohan, M.D.
View Course
More

Management of Non-Valvular Atrial Fibrillation – The New Era of Oral Anticoagulants

The most important feature which distinguishes AF from other atrial arrhythmias is the absence of P waves.
Authors: Muhib Khan, M.D., and Karen Furie, M.D., M.P.H.
View Course
More

Current Management of Acute Decompensated Heart Failure

The rate of hospitalization for acute decompensated heart failure will continue to increase because of an aging population.
Authors: Joel Schilling, M.D., Ph.D.
View Course
More

Pharmacological Therapy of Cardiac Arrhythmias: Atrial Fibrillation, Current Treatment and Novel Agents

Cardiac arrhythmias may be seen in individuals with known cardiovascular disease (i.e., coronary artery disease (CAD) or valvular abnormalities) or even in those without known cardiac illnesses. The spectrum of cardiac arrhythmias varies between more self-limited or minimally symptomatic findings such as palpitations, which may be associated with premature supraventricular or ventricular beats that many experience, to the more worrisome ventricular fibrillation, a known cause of sudden cardiac arrest for which emergency cardiac resuscitation is required. of cardiac arrhythmias varies between more self-limited or minimally symptomatic findings such as palpitations, which may be associated with premature supraventricular or ventricular beats that many experience, to the more worrisome ventricular fibrillation, a known cause of sudden cardiac arrest for which emergency cardiac resuscitation is required.
Authors: Mohan N. Viswanathan, M.D.
View Course
More

Suppression of the Renin-Angiotensin-Aldosterone System

The renin-angiotensin-aldosterone system (RAS) is involved in the development of hypertension and its associated complications.
Authors: Samer Ellahham, M.D. and Helmy M. Siragy, M.D.
View Course
More